Can BlissBio’s HER2-Targeting ADC Challenge Enhertu In Breast Cancer?

Eisai Deal Sets Stage For Battle

 
• By Dexter Jie Yan
  
challenger facing hurdles
Any serious challenger to Enhertu will face hurdles, especially in breast cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia